Building upon this background knowledge, in the present study we investigated the putative pathological roles for GSK3β in ESCC and explored the effects of GSK3β inhibition against this tumor type and the underlying biological mechanisms. This evidence concerns the gene GSK3B and esophageal squamous cell carcinoma.